Skip to main content Help with accessibility Skip to main navigation

SOLRIAMFETOL HYDROCHLORIDE tablets (Sunosi®▼) for treating excessive daytime sleepiness caused by obstructive sleep apnoea

CCG Approval Status:

Ha
Kn
Li
SF
SS
SH
Wa
WL
Wi
Date Added: 24 - Mar - 2022
Body System:
Black
SOLRIAMFETOL HYDROCHLORIDE tablets (Sunosi®▼) for treating excessive daytime sleepiness caused by obstructive sleep apnoea

The Pan Mersey Area Prescribing Committee does not recommend the prescribing of SOLIRAMFETOL tablets (Sunosi®▼), for treating excessive daytime sleepiness caused by obstructive sleep apnoea in accordance with NICE TA777.